Thyroid hormone in health and disease

Journal of Endocrinology

Volumn 187, Issue 1, 2005, Pages 1-15

  Boelaert, K ^a   Franklyn, J A ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; ANTITHYROID AGENT; IODINE 131; LIOTHYRONINE; MONOCARBOXYLATE TRANSPORTER; PLACEBO; RADIOACTIVE IODINE; THYROID HORMONE; THYROMIMETIC AGENT; THYROXINE;

BRAIN CANCER; BRAIN DEVELOPMENT; BREAST CANCER; CANCER INCIDENCE; CANCER RISK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CARDIOVERSION; CLINICAL TRIAL; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SAFETY; EMBOLISM; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HORMONE SUBSTITUTION; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; INCIDENCE; ISCHEMIC HEART DISEASE; KIDNEY CANCER; LEUKEMIA; META ANALYSIS; MORBIDITY; MORTALITY; NONHUMAN; OSTEOPOROSIS; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SOLID TUMOR; STOMACH CANCER; SURVIVAL RATE; SYSTEMATIC REVIEW; THYROID CANCER; THYROID DISEASE; THYROID SURGERY; THYROTOXICOSIS;

ATHEROSCLEROSIS; BRAIN; DEMENTIA; FEMALE; HUMANS; INCIDENCE; MALE; MORBIDITY; OSTEOPOROSIS; PREGNANCY; PREGNANCY COMPLICATIONS; RISK; THYROID DISEASES; THYROID HORMONES;

EID: 27644543916     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.1.06131     Document Type: Review

References (112)

1. Alexander EK, Marqusee E, Lawrence J, Jarolim P, Fischer GA & Larsen PR 2004 Timing and magnitude of increases in levothyroxine requirements during pregnancy in women with hypothyroidism. New England Journal of Medicine 351 241-249.
2. Auer J, Scheibner P, Mische T, Langsteger W, Eber O & Eber B 2001 Subclinical hyperthyroidism as a risk factor for atrial fibrillation. American Heart Journal 142 838-842.
3. Bar-Sela S, Ehrenfeld M & Eliakim M 1981 Arterial embolism in thyrotoxicosis with atrial fibrillation. Archives of Internal Medicine 141 1191-1192.
4. Bauer DC, Ettinger B, Nevitt MC & Stone KL 2001 Risk for fracture in women with low serum levels of thyroid-stimulating hormone. Annals of Internal Medicine 134 561-568.
5. Baxter MA, Stewart PM, Daykin J, Sheppard MC & Franklyn JA 1993 Radioiodine therapy for hyperthyroidism in young patients - perception of risk and use. Quarterly Journal of Medicine 86 495-499.
6. Bettendorf M, Schmidt KG, Grulich-Henn J, Ulmer HE & Heinrich UE 2000 Tri-iodothyronine treatment in children after cardiac surgery: a double-blind, randomised, placebo-controlled study. Lancet 356 529-534.
7. Biondi B, Fazio S, Carella C, Sabatini D, Amato G, Cittadini A, Bellastella A, Lombardi G & Sacca L 1994 Control of adrenergic overactivity by beta-blockade improves the quality of life in patients receiving long term suppressive therapy with levothyroxine. Journal of Clinical Endocrinology and Metabolism 78 1028-1033.
8. Biondi B, Palmieri EA, Fazio S, Cosco C, Nocera M, Sacca L, Filetti S, Lombardi G & Perticone F 2000 Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients. Journal of Clinical Endocrinology and Metabolism 85 4701-4705.
9. Blank B, Pfeiffer FR, Greenberg CM & Kerwin JF 1963 Thyromimetics. I. The synthesis and hypocholesteremic activity of some 3′ and 3′,5′-alkyl and aryl-3,5-diiodothyronines. Journal of Medicinal Chemistry 19 554-560.
10. Boelaert K & Franklyn JA 2003 Sodium iodide symporter: a novel strategy to target breast, prostate, and other cancers? Lancet 361 796-797.
11. Canaris GJ, Manowitz NR, Mayor G & Ridgway EC 2000 The Colorado thyroid disease prevalence study. Archives of Internal Medicine 160 526-534.
12. Cappola AR & Ladenson PW 2003 Hypothyroidism and atherosclerosis. Journal of Clinical Endocrinology and Metabolism 88 2438-2444.
13. Caraccio N, Ferrannini E & Monzani F 2002 Lipoprotein profile in subclinical hypothyroidism: response to levothyroxine replacement, a randomized placebo-controlled study. Journal of Clinical Endocrinology and Metabolism 87 1533-1538.
14. Chiellini G, Apriletti JW, Yoshihara HA, Baxter JD, Ribeiro RC & Scanlan TS 1998 A high-affinity subtype-selective agonist ligand for the thyroid hormone receptor. Chemistry and Biology 5 299-306.
15. Cummings SR, Nevitt MC, Browner WS, Stone K, Fox KM, Ensrud KE, Cauley J, Black D & Vogt TM 1995 Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. New England Journal of Medicine 332 767-773.
16. Darling DS, Carter RL, Yen PM, Welborn JM, Chin WW & Umeda PK 1993 Different dimerization activities of alpha and beta thyroid hormone receptor isoforms. Journal of Biological Chemistry 268 10221-10227.
17. Davies PH, Franklyn JA, Daykin J & Sheppard MC 1992 The significance of TSH values measured in a sensitive assay in the follow-up of hyperthyroid patients treated with radioiodine. Journal of Clinical Endocrinology and Metabolism 74 1189-1194.
18. Dean JW & Fowler PB 1985 Exaggerated responsiveness to thyrotrophin releasing hormone: a risk factor in women with coronary artery disease. British Medical Journal 290 1555-1561.
19. 131I: a population-based cohort study in Sweden. International Journal of Cancer 106 580-587.
20. Drinka PJ, Amberson J, Voeks SK, Schomisch J, Schirz P & Christensen D 1996 Low TSH levels in nursing home residents not taking thyroid hormone. Journal of the American Geriatric Society 44 573-577.
21. Dumitrescu AM, Liao XH, Best TB, Brockmann K & Refetoff S 2004 A novel syndrome combining thyroid and neurological abnormalities is associated with mutations in a monocarboxylate transporter gene. American Journal of Human Genetics 74 168-175.
22. Faber J & Galloe AM 1994 Changes in bone mass during prolonged subclinical hyperthyroidism due to L-thyroxine treatment: a meta-analysis. European Journal of Endocrinology 130 350-356.
23. Fatourechi V 2001 Adverse effects of subclinical hyperthyroidism. Lancet 358 856-857.
24. Fisher DA 1997 Fetal thyroid function: diagnosis and management of fetal thyroid disorders. Clinical Obstetrics and Gynecology 40 16-31.
25. Fisher DA, Dussault JH, Sack J & Chopra IJ 1976 Ontogenesis of hypothalamic-pituitary-thyroid function and metabolism in man, sheep, and rat. Recent Progress in Hormone Research 33 59-116.
26. Forfar JC, Miller HC & Toft AD 1979 Occult thyrotoxicosis: a correctable cause of 'idiopathic' atrial fibrillation. American Journal of Cardiology 44 9-12.
27. Franklyn JA & Sheppard MC 1990 Thyroxine replacement treatment and osteoporosis. British Medical Journal 300 693-694.
28. Franklyn JA, Daykin J, Drolc Z, Farmer M & Sheppard MC 1991 Long-term follow-up of treatment of thyrotoxicosis by three different methods. Clinical Endocrinology 34 71-76.
29. Franklyn JA, Betteridge J, Daykin J, Holder R, Oates GD, Parle JV, Lilley J, Heath DA & Sheppard MC 1992 Long-term thyroxine treatment and bone mineral density. Lancet 340 9-13.
30. Franklyn JA, Betteridge J, Holder R, Daykin J, Lilley J & Sheppard M 1994 Bone mineral density in thyroxine treated females with or without a previous history of thyrotoxicosis. Clinical Endocrinology 41 425-432.
31. Franklyn JA, Maisonneuve P, Sheppard MC, Betteridge J & Boyle P 1998 Mortality after the treatment of hyperthyroidism with radioactive iodine. New England Journal of Medicine 338 712-718.
32. Franklyn JA, Maisonneuve P, Sheppard M, Betteridge J & Boyle P 1999 Cancer incidence and mortality after radioiodine treatment for hyperthyroidism: a population-based cohort study. Lancet 353 2111-2115.
33. Friesema EC, Ganguly S, Abdalla A, Manning Fox JE, Halestrap AP & Visser TJ 2003 Identification of monocarboxylate transporter 8 as a specific thyroid hormone transporter. Journal of Biological Chemistry 278 40128-40135.
34. Friesema EC, Grueters A, Biebermann H, Krude H, von Moers A, Reeser M, Barrett TG, Mancilla EE, Svensson J, Kester MH et al. 2004 Association between mutations in a thyroid hormone transporter and severe X-linked psychomotor retardation. Lancet 364 1435-1437.
35. 131I doses from Nevada atmospheric nuclear bomb tests. Journal of the National Cancer Institute 90 1654-1660.
36. Gilligan DM, Ellenbogen KA & Epstein AE 1996 The management of atrial fibrillation. American Journal of Medicine 101 413-421.
37. Girvent M, Maestro S, Hernandez R, Carajol I, Monne J, Sancho JJ, Gubern JM & Sitges-Serra A 1998 Euthyroid sick syndrome, associated endocrine abnormalities, and outcome in elderly patients undergoing emergency operation. Surgery 123 560-567.
38. Goldman MB, Maloof F, Monson RR, Aschengrau A, Cooper DS & Ridgway EC 1988 Radioactive iodine therapy and breast cancer. A follow-up study of hyperthyroid women. American Journal of Epidemiology 127 969-980.
39. Goldman MB, Monson RR & Maloof F 1990 Cancer mortality in women with thyroid disease. Cancer Research 50 2283-2289.
40. Graves RJ 1835 Clinical lectures delivered by Robert J. Graves, M.D., at the Meath Hospital during the Session of 1834-1835. London Medical and Surgical Journal 7 516.
41. Grover GJ, Egan DM, Sleph PG, Beehler BC, Chiellini G, Nguyen NH, Baxter JD & Scanlan TS 2004 Effects of the thyroid hormone receptor agonist GC-1 on metabolic rate and cholesterol in rats and primates: selective actions relative to 3,5,3′-triiodo-L-thyronine. Endocrinology 145 1656-1661.
42. Gull WW 1874 On a cretinoid state supervening in adult life in women. Transactions of the Clinical Society London 7 180.
43. Haddow JE, Palomaki GE, Allan WC, Williams JR, Knight GJ, Gagnon J, O'Heir CE, Mitchell ML, Hermos RJ, Waisbren SE et al. 1999 Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. New England Journal of Medicine 341 549-555.
44. Hak AE, Pols HA, Visser TJ, Drexhage HA, Hofman A & Witteman JC 2000 Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Annals of Internal Medicine 132 270-278.
45. Hall P, Berg G, Bjelkengren G, Boice JD Jr, Ericsson UB, Hallquist A, Lidberg M, Lundell G, Tennvall J & Wiklund K 1992a Cancer mortality after iodine-131 therapy for hyperthyroidism. International Journal of Cancer 50 886-890.
46. Hall P, Boice JD Jr, Berg G, Bjelkengren G, Ericsson UB, Hallquist A, Lidberg M, Lundell G, Mattsson A & Tennvall J 1992b Leukaemia incidence after iodine-131 exposure. Lancet 340 1-4.
47. Hall P, Lundell G & Holm LE 1993 Mortality in patients treated for hyperthyroidism with iodine-131. Acta Endocrinologica 128 230-234.
48. Hanna FW, Pettit RJ, Ammari F, Evans WD, Sandeman D & Lazarus JH 1998 Effect of replacement doses of thyroxine on bone mineral density. Clinical Endocrinology 48 229-234.
49. Hegedus L, Bonnema SJ & Bennedbaek FN 2003 Management of simple nodular goiter: current status and future perspectives. Endocrine Reviews 24 102-132.
50. Hennemann G, Docter R, Friesema EC, de Jong M, Krenning EP & Visser TJ 2001 Plasma membrane transport of thyroid hormones and its role in thyroid hormone metabolism and bioavailability. Endocrine Reviews 22 451-476.
51. Hoffman DA, McConahey WM, Diamond EL & Kurland LT 1982 Mortality in women treated for hyperthyroidism. American Journal of Epidemiology 115 243-254.
52. Holm LE, Hall P, Wiklund K, Lundell G, Berg G, Bjelkengren G, Cederquist E, Ericsson UB, Hallquist A & Larsson LG 1991 Cancer risk after iodine-131 therapy for hyperthyroidism. Journal of the National Cancer Institute 83 1072-1077.
53. Kalmijn S, Mehta KM, Pols HA, Hofman A, Drexhage HA & Breteler MM 2000 Subclinical hyperthyroidism and the risk of dementia. The Rotterdam study. Clinical Endocrinology 53 733-737.
54. Keating FR Jr, Parkin TW, Selby JB & Dickinson LS 1961 Treatment of heart disease associated with myxedema. Progress in Cardiovascular Diseases 3 364-381.
55. Kempers MJ, van Tijn DA, van Trotsenburg AS, de Vijlder JJ, Wiedijk BM & Vulsma T 2003 Central congenital hypothyroidism due to gestational hyperthyroidism: detection where prevention failed. Journal of Clinical Endocrinology and Metabolism 88 5851-5857.
56. Kendall EC 1915 The isolation in crystalline form of the compound which occurs in the thyroid: its chemical nature and physiologic activity. Journal of the American Medical Association 64 2042.
57. Kibirige MS, Hutchison S, Owen CJ & Delves HT 2004 Prevalence of maternal dietary iodine insufficiency in the north east of England: implications for the fetus. Archives of Diseases in Childhood (Fetal and Neonatal Edition) 89 F436-F439.
58. Klein I & Ojamaa K 2001 Thyroid hormone and the cardiovascular system. New England Journal of Medicine 344 501-509.
59. Klein RZ, Haddow JE, Faix JD, Brown RS, Hermos RJ, Pulkkinen A & Mitchell ML 1991 Prevalence of thyroid deficiency in pregnant women. Clinical Endocrinology 35 41-46.
60. Klemperer JD, Klein I, Gomez M, Helm RE, Ojamaa K, Thomas SJ, Isom OW & Krieger K 1995 Thyroid hormone treatment after coronary-artery bypass surgery. New England Journal of Medicine 333 1522-1527.
61. Krahn AD, Klein GJ, Kerr CR, Boone J, Sheldon R, Green M, Talajic M, Wang X & Connolly S 1996 How useful is thyroid function testing in patients with recent-onset atrial fibrillation? The Canadian Registry of Atrial Fibrillation Investigators. Archives of Internal Medicine 156 2221-2224.
62. Lazar MA 1993 Thyroid hormone receptors: multiple forms, multiple possibilities. Endocrine Reviews 14 184-193.
63. Leese GP, Jung RT, Guthrie C, Waugh N & Browning MC 1992 Morbidity in patients on L-thyroxine: a comparison of those with a normal TSH to those with a suppressed TSH. Clinical Endocrinology 37 500-503.
64. Luboshitzky R, Aviv A, Herer P & Lavie L 2002 Risk factors for cardiovascular disease in women with subclinical hypothyroidism. Thyroid 12 421-425.
65. Maldonado LS, Murata GH, Hershman JM & Braunstein GD 1992 Do thyroid function tests independently predict survival in the critically ill? Thyroid 2 119-123.
66. Mellemgaard A, From G, Jorgensen T, Johansen C, Olsen JH & Perrild H 1998 Cancer risk in individuals with benign thyroid disorders. Thyroid 8 751-754.
67. Moysich KB, Menezes RJ & Michalek AM 2002 Chernobyl-related ionising radiation exposure and cancer risk: an epidemiological review. Lancet Oncology 3 269-279.
68. Munoz A & Bernal J 1997 Biological activities of thyroid hormone receptors. European Journal of Endocrinology 137 433-445.
69. Nakazawa HK, Sakurai K, Hamada N, Momotani N & Ito K 1982 Management of atrial fibrillation in the post-thyrotoxic state. American Journal of Medicine 72 903-906.
70. Nordyke RA, Gilbert FI Jr & Harada AS 1988 Graves' disease. Influence of age on clinical findings. Archives of Internal Medicine 148 626-631.
71. Parle JV, Franklyn JA, Cross KW, Jones SC & Sheppard MC 1991 Prevalence and follow-up of abnormal thyrotrophin (TSH) concentrations in the elderly in the United Kingdom. Clinical Endocrinology 34 77-83.
72. Parle JV, Franklyn JA, Cross KW, Jones SR & Sheppard MC 1993 Thyroxine prescription in the community: serum thyroid stimulating hormone level assays as an indicator of undertreatment or overtreatment. British Journal of General Practice 43 107-109.
73. Parle JV, Maisonneuve P, Sheppard MC, Boyle P & Franklyn JA 2001 Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study. Lancet 358 861-865.
74. Paul TL, Kerrigan J, Kelly AM, Braverman LE & Baran DT 1988 Long-term L-thyroxine therapy is associated with decreased hip bone density in premenopausal women. Journal of the American Medical Association 259 3137-3141.
75. Petersen P & Hansen JM 1988 Stroke in thyrotoxicosis with atrial fibrillation. Stroke 19 15-18.
76. Pop VJ, de Vries E, van Baar AL, Waelkens JJ, de Rooy HA, Horsten M, Donkers MM, Komproe IH, van Son MM & Vader HL 1995 Maternal thyroid peroxidase antibodies during pregnancy: a marker of impaired child development? Journal of Clinical Endocrinology and Metabolism 80 3561-3566.
77. Pop VJ, Kuijpens JL, van Baar AL, Verkerk G, van Son MM, de Vijlder JJ, Vulsma T, Wiersinga WM, Drexhage HA & Vader HL 1999 Low maternal free thyroxine concentrations during early pregnancy are associated with impaired psychomotor development in infancy. Clinical Endocrinology 50 149-155.
78. Pop VJ, Brouwers EP, Vader HL, Vulsma T, van Baar AL & de Vijlder JJ 2003 Maternal hypothyroxinaemia during early pregnancy and subsequent child development: a 3-year follow-up study. Clinical Endocrinology 59 282-288.
79. Portman MA, Fearneyhough C, Ning XH, Duncan BW, Rosenthal GL & Lupinetti FM 2000 Triiodothyronine repletion in infants during cardiopulmonary bypass for congenital heart disease. Journal of Thoracic and Cardiovascular Surgery 120 604-608.
80. Presti CF & Hart RG 1989 Thyrotoxicosis, atrial fibrillation, and embolism, revisited. American Heart Journal 117 976-977.
81. Ron E, Doody MM, Becker DV, Brill AB, Curtis RE, Goldman MB, Harris BS III, Hoffman DA, McConahey WM, Maxon HR et al. 1998 Cancer mortality following treatment for adult hyperthyroidism. Cooperative Thyrotoxicosis Therapy Follow-up Study Group. Journal of the American Medical Association 280 347-355.
82. Ross DS 1994 Hyperthyroidism, thyroid hormone therapy, and bone. Thyroid 4 319-326.
83. Ross DS, Neer RM, Ridgway EC & Daniels GH 1987 Subclinical hyperthyroidism and reduced bone density as a possible result of prolonged suppression of the pituitary-thyroid axis with L-thyroxine. American Journal of Medicine 82 1167-1170.
84. Sandler G & Wilson GM 1959 The nature and prognosis of heart disease in thyrotoxicosis. A review of 150 patients treated with 131 I. Quarterly Journal of Medicine 28 347-369.
85. Sawin CT, Geller A, Wolf PA, Belanger AJ, Baker E, Bacharach P, Wilson PW, Benjamin EJ & D'Agostino RB 1994 Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. New England Journal of Medicine 331 1249-1252.
86. Sawin CT 2000 The heritage of the thyroid. In Werner & Ingbar's The Thyroid, edn 8, pp 3-6. Eds LE Braverman & RD Utiger. Philadelphia, USA: Lippincott Williams & Wilkins.
87. Scanlan TS, Yoshihara HA, Nguyen NH & Chiellini G 2001 Selective thyromimetics: tissue-selective thyroid hormone analogs. Current Opinion in Drug Discovery and Development 4 614-622.
88. Schaefer U, Hesselmann S, Micke O, Schueller P, Bruns F, Palma C & Willich N 2002 A long-term follow-up study after retro-orbital irradiation for Graves' ophthalmopathy. International Journal of Radiation Oncology, Biology, Physics 52 192-197.
89. Schulte C, Reinhardt W, Beelen D, Mann K & Schaefer U 1998 Low T3-syndrome and nutritional status as prognostic factors in patients undergoing bone marrow transplantation. Bone Marrow Transplantation 22 1171-1178.
90. Seeley DG, Kelsey J, Jergas M & Nevitt MC 1996 Predictors of ankle and foot fractures in older women. The Study of Osteoporotic Fractures Research Group. Journal of Bone and Mineral Research 11 1347-1355.
91. Shepard TH 1967 Onset of function in the human fetal thyroid: biochemical and radioautographic studies from organ culture. Journal of Clinical Endocrinology and Metabolism 27 945-958.
92. Sheppard MC, Holder R & Franklyn JA 2002 Levothyroxine treatment and occurrence of fracture of the hip. Archives of Internal Medicine 162 338-343.
93. Spencer CA, LoPresti JS, Patel A, Guttler RB, Eigen A, Shen D, Gray D & Nicoloff JT 1990 Applications of a new chemiluminometric thyrotropin assay to subnormal measurement. Journal of Clinical Endocrinology and Metabolism 70 453-460.
94. Steinberg AD 1968 Myxedema and coronary artery disease - a comparative autopsy study. Annals of Internal Medicine 68 338-344.
95. Sullivan M 2004 American Thyroid Association Statement: Subclinical hypothyroidism before conception. Ob. Gyn. News 2004, available at http://www2.eObGynNews.com, Sect. 1-4. 1/5/2004.
96. Surks MI, Ortiz E, Daniels GH, Sawin CT, Col NF, Cobin RH, Franklyn JA, Hershman JM, Burman KD, Denke MA et al. 2004 Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. Journal of the American Medical Association 291 228-238.
97. Taylor AH, Stephan ZF, Steele RE & Wong NC 1997 Beneficial effects of a novel thyromimetic on lipoprotein metabolism. Molecular Pharmacology 52 542-547.
98. Thorpe-Beeston JG, Nicolaides KH, Felton CV, Butler J & McGregor AM 1991 Maturation of the secretion of thyroid hormone and thyroid-stimulating hormone in the fetus. New England Journal of Medicine 324 532-536.
99. Tieche M, Lupi GA, Gutzwiller F, Grob PJ, Studer H & Burgi H 1981 Borderline low thyroid function and thyroid autoimmunity. Risk factors for coronary heart disease? British Heart Journal 46 202-206.
100. Tunbridge WM, Evered DC, Hall R, Appleton D, Brewis M, Clark F, Evans JG, Young E, Bird T & Smith PA 1977 The spectrum of thyroid disease in a community: the Whickham survey. Clinical Endocrinology 7 481-493.
101. Turken O, NarIn Y, DemIrbas S, Onde ME, Sayan O, KandemIr EG, YaylacI M & Ozturk A 2003 Breast cancer in association with thyroid disorders: Breast Cancer Research 5 R110-R113.
102. Uzzan B, Campos J, Cucherat M, Nony P, Boissel JP & Perret GY 1996 Effects on bone mass of long term treatment with thyroid hormones: a meta-analysis. Journal of Clinical Endocrinology and Metabolism 81 4278-4289.
103. Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, Grimley EJ, Hasan DM, Rodgers H & Tunbridge F 1995 The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clinical Endocrinology 43 55-68.
104. Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, Grimley EJ, Rodgers H, Tunbridge F & Young ET 1996 The development of ischemic heart disease in relation to autoimmune thyroid disease in a 20-year follow-up study of an English community. Thyroid 6 155-160.
105. Vanhaelst L, Neve P, Chailly P & Bastenie PA 1967 Coronary-artery disease in hypothyroidism. Observations in clinical myxoedema. Lancet 2 800-802.
106. Vestergaard P & Mosekilde L 2002 Fractures in patients with hyperthyroidism and hypothyroidism: a nationwide follow-up study in 16249 patients. Thyroid 12 411-419.
107. Vexiau P, Perez-Castiglioni P, Socie G, Devergie A, Toubert ME, Aractingi S & Gluckman E 1993 The 'euthyroid sick syndrome': incidence, risk factors and prognostic value soon after allogeneic bone marrow transplantation. British Journal of Haematology 85 778-782.
108. Wharton T 1664 Adenographia: sive glandularum totius corporis desriptio. Noviomagi (now Nijmegen): Andreas ab Hoogenhuyse (This endocrine classic has been translated into English. See: Freer S, translator. Thomas Wharton's Adenographia. Oxford, England: Clarendon Press 1996).
109. Williams GR 2000 Cloning and characterization of two novel thyroid hormone receptor beta isoforms. Molecular and Cellular Biology 20 8329-8342.
110. Yen PM 2001 Physiological and molecular basis of thyroid hormone action. Physiology Reviews 81 1097-1142.
111. Zindrou D, Taylor KM & Bagger JP 2002 Excess coronary artery bypass graft mortality among women with hypothyroidism. Annals of Thoracic Surgery 74 2121-2125.
112. Zoeller RT & Rovet J 2004 Timing of thyroid hormone action in the developing brain: clinical observations and experimental findings. Journal of Neuroendocrinology 16 809-818.